Drug Approval | September 06, 2021
Alembic JV Aleor receives US FDA final approval for skin disorder gel
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
At present 18 per cent of the local pharmaceutical market is under government's price control
The investment is part of the group's digital health initiatives, to foster affordable access to world-class technology and an innovation-led healthcare ecosystem in India
The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL
RSV is a common and pervasive cause of severe acute respiratory illness in older adults with no vaccine currently available
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
The company has been sold to Shinshin Pharmaceuticals
Invega Hafyera offers patients the fewest doses per year. Phase 3 non-inferiority study results showed over 92% of participants were relapse-free at 12 months
The drug is also intended for the treatment of glioblastoma multiforme
The segment delivered strong sales growth of 20% YoY
Subscribe To Our Newsletter & Stay Updated
